These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34752621)

  • 41. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome.
    Unlühizarci K; Ozocak M; Tanriverdi F; Atmaca H; Keleştimur F
    Fertil Steril; 2007 Jun; 87(6):1377-82. PubMed ID: 17336975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.
    Aroda V; Ciaraldi TP; Chang SA; Dahan MH; Chang RJ; Henry RR
    Fertil Steril; 2008 May; 89(5):1200-1208. PubMed ID: 17706206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
    Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.
    Flannery CA; Rackow B; Cong X; Duran E; Selen DJ; Burgert TS
    Pediatr Diabetes; 2013 Feb; 14(1):42-9. PubMed ID: 22925367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharmacol; 2023 Sep; 63(9):1045-1052. PubMed ID: 37173821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.
    Sam S; Sung YA; Legro RS; Dunaif A
    Metabolism; 2008 Jan; 57(1):84-9. PubMed ID: 18078863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.
    Baillargeon JP; Carpentier AC
    Diabetologia; 2007 Dec; 50(12):2424-32. PubMed ID: 17898989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Yilmaz B; Vellanki P; Ata B; Yildiz BO
    Fertil Steril; 2018 Aug; 110(3):523-533.e14. PubMed ID: 29960703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
    Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
    Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysregulation of glucose metabolism even in Chinese PCOS women with normal glucose tolerance.
    Li W; Li Q
    Endocr J; 2012; 59(9):765-70. PubMed ID: 22673295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.
    Trottier A; Battista MC; Geller DH; Moreau B; Carpentier AC; Simoneau-Roy J; Baillargeon JP
    Fertil Steril; 2012 Dec; 98(6):1627-34. PubMed ID: 22985947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Ehrmann DA; Cavaghan MK; Imperial J; Sturis J; Rosenfield RL; Polonsky KS
    J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using simple clinical measures to predict insulin resistance or hyperglycemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Cai N; Thurston JE; Coe GV; Newnes L; Garcia-Reyes Y; Baumgartner AD; Pyle L; Nadeau KJ
    Pediatr Diabetes; 2018 Dec; 19(8):1370-1378. PubMed ID: 30246333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level.
    Bu Z; Kuok K; Meng J; Wang R; Xu B; Zhang H
    Reprod Biol Endocrinol; 2012 Feb; 10():10. PubMed ID: 22309801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
    Nestler JE; Jakubowicz DJ
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4075-9. PubMed ID: 9398716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.